Literature DB >> 24434685

Therapeutic efficacy of topical calcineurin inhibitors in plasma cell balanitis: case series and review of the literature.

A Kyriakou1, A Patsatsi, C Patsialas, D Sotiriadis.   

Abstract

Plasma cell balanitis of Zoon (PCBZ) and plasma cell vulvitis (PCV) are characterized as idiopathic, benign, chronic irritant mucositis. The clinical symptoms and signs usually persist or reappear after treatment withdrawal. Therefore, many therapies have been tried and are available. Recently, several reports of PCBZ and PCV treated with calcineurin inhibitors, tacrolimus and pimecrolimus, have been reported in the literature. We present 9 cases of PCBZ treated with tacrolimus 0.1% ointment (Protopic, Toyama, Japan) that showed good therapeutic results within 4 weeks of treatment, and we review the literature of PCBZ and PCV and their response to these topical immunomodulators. Based on the current literature and on the anecdotal experience, we believe that topical calcineurin inhibitors may serve as a therapeutic option in recalcitrant plasma cell balanitis and vulvitis.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24434685     DOI: 10.1159/000357153

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  4 in total

1.  Zoon vulvitis.

Authors:  Leandro Damiani; Maurício de Quadros; Váruna Posser; Renan Minotto; Ana Letícia Boff
Journal:  An Bras Dermatol       Date:  2017       Impact factor: 1.896

2.  [Differential diagnosis and management of balanitis].

Authors:  S Borelli; S Lautenschlager
Journal:  Hautarzt       Date:  2015-01       Impact factor: 0.751

Review 3.  Zoon balanitis: A comprehensive review.

Authors:  Surabhi Dayal; Priyadarshini Sahu
Journal:  Indian J Sex Transm Dis AIDS       Date:  2016 Jul-Dec

Review 4.  Successful Management of Zoon's Balanitis with Topical Mupirocin Ointment: A Case Report and Literature Review of Mupirocin-Responsive Balanitis Circumscripta Plasmacelluaris.

Authors:  Omar Bari; Philip R Cohen
Journal:  Dermatol Ther (Heidelb)       Date:  2017-04-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.